Neurogene Inc.
NGNE | NASDAQ
$32.57
+$0.48 (+1.50%)
At close: Sep 21, 2026, 4:00 PM ET
$32.57
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | 925K | n/a | n/a | n/a | n/a |
Cost of Revenue | 3.19M | 3.25M | 3.26M | 3.2M | 42.26M | 1.82M |
Gross Profit | -3.19M | -2.32M | -3.26M | -3.2M | -42.26M | -1.82M |
Operating Income | -103.21M | -82.61M | -55.58M | -56.52M | -50.53M | -41.55M |
Interest Income | 11.55M | 8.47M | 2.95M | 1.34M | 19K | 490K |
Pretax Income | -90.35M | -75.14M | -36.32M | -55.19M | -50.52M | -33.28M |
Net Income | -90.35M | -75.14M | -36.32M | -55.19M | -50.52M | -33.28M |
Selling & General & Admin | 25.13M | 22.61M | 11.19M | 9.01M | 8.27M | 15.39M |
Research & Development | 75.01M | 60.92M | 44.39M | 47.51M | 42.26M | 24.34M |
Other Expenses | n/a | -3.25M | -3.26M | -3.2M | -42.26M | n/a |
Operating Expenses | 100.02M | 80.28M | 52.32M | 53.32M | 8.27M | 39.73M |
Interest Expense | 5K | 12K | 12K | 2K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 103.21M | 83.53M | 55.58M | 56.52M | 50.53M | 41.55M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 21.17M | 17.57M | 12.82M | 12.82M | 55.04M | 51.83M |
Shares Outstanding (Diluted) | 21.17M | 17.57M | 12.82M | 12.82M | 55.04M | 51.83M |
EPS (Basic) | -4.24 | -4.28 | -2.83 | -4.30 | -0.92 | -0.64 |
EPS (Diluted) | -4.24 | -4.28 | -2.83 | -4.30 | -0.92 | -0.64 |
EBITDA | -87.25M | -71.89M | -33.01M | -51.99M | -49.57M | -31.46M |
EBIT | -90.35M | -75.13M | -36.31M | -55.19M | -50.52M | -33.28M |
Depreciation & Amortization | 3.09M | 3.25M | 3.3M | 3.2M | 947K | 1.82M |
Add to Watchlist
Select watchlists to add or remove NGNE